SCHEMBL3948433

SCHEMBL3948433

CCOc1ccc(C(=CC=CC(=O)O)c2ccc(C)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.56
PARP10 Q53GL7 2/20 0.50
MAOA P21397 1/20 0.47
MAPT P10636 4/20 0.46
ALDH1A1 P00352 3/20 0.46
HTT P42858 2/20 0.46
POLB P06746 1/20 0.46
RECQL P46063 1/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
PPARG P37231 1/20 0.46
PPARD Q03181 1/20 0.46
PPARA Q07869 1/20 0.46
PLA2G4B P0C869 1/20 0.46
NPC1 O15118 2/20 0.44
PLK1 P53350 1/20 0.44
LMNA P02545 1/20 0.44
THRB P10828 1/20 0.44
HPGD P15428 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3947567 1.00 MAOB (0.56) MAOBPARP10MAOAMAPTALDH1A1
SCHEMBL3948430 1.00 MAOB (0.56) MAOBPARP10MAOAMAPTALDH1A1
SCHEMBL3938861 0.94 PARP10 (0.56) MAOBPARP10MAOAMAPTALDH1A1
SCHEMBL3938871 0.94 PARP10 (0.56) MAOBPARP10MAOAMAPTALDH1A1
SCHEMBL3938801 0.88 MAOB (0.56) MAOBPARP10MAOAMAPTALDH1A1
SCHEMBL3938809 0.88 MAOB (0.56) MAOBPARP10MAOAMAPTALDH1A1
SCHEMBL3938811 0.88 MAOB (0.56) MAOBPARP10MAOAMAPTALDH1A1
SCHEMBL4102553 0.85 ALDH1A1 (0.58) MAPTALDH1A1HTTPOLBKMT2A
SCHEMBL4102547 0.85 ALDH1A1 (0.58) MAPTALDH1A1HTTPOLBKMT2A
SCHEMBL3940154 0.84 CYP1A1 (0.59) MAOBPARP10MAOAKMT2APLA2G4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203667-A1 PENTADIENAMIDE DERIVATIVES KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-08-13 US disclosed
EP-2050734-A1 PENTADIENAMIDE DERIVATIVE Kyowa Hakko Kirin Co., Ltd. (JP) 2009-04-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203667-A1 PENTADIENAMIDE DERIVATIVES PRMT1, REN, NGLY1 MAOB 747/4885PARP10 1526/4885MAOA 1455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.